Gait patterns after intraarticular treatment of patients with osteoarthritis of the knee--hyaluronan versus triamcinolone: a prospective, randomized, doubleblind, monocentric study

A Skwara, R Ponelis, C O Tibesku, D Rosenbaum, S Fuchs-Winkelmann, A Skwara, R Ponelis, C O Tibesku, D Rosenbaum, S Fuchs-Winkelmann

Abstract

Objective: Evaluation of gait performance and muscle activity patterns as well as clinical efficacy and safety after single intraarticular injection with hyaluronan compared with triamcinolone in patients with knee osteoarthritis.

Materials and methods: This trial evaluated the influence of a single injection of hyaluronan or triamcinolone on gait pattern and muscle activity. For clinical evaluation a visual analogue scale for pain, Lequesne index, and Knee Society Score were used. Quality of life was assessed with the SF-36.

Results: The complete analysis was performed in 50 of 60 patients. 26 patients were treated with triamcinolone and 24 with hyaluronan. Hyaluronan treatment led to significant improvement of range of motion at hip and knee. Significant improvement could be either demonstrated for the pain scale, Lequesne and Knee Society score in both groups. Quality of life showed greater improvement in the triamcinolone group.

Conclusion: Single application of high-viscosity hyaluronan shows superior range of motion and pain reduction as well as improvement in clinical results. Even if there was a lack of significant differences compared to triamcinolone, this therapy classified as safe and effective in the short follow up.

Figures

Figure 1
Figure 1
Results of the eight items of the SF-36 quality of life questionnaire of the HA, TA and a group of healthy German individuals of the same age. (Physical Functioning -PF, Role Physical -RP, Bodily Pain -BP, General Health Perceptions -GH, Vitality -VT, Social Functioning -SF, Role Emotional -RE, Mental Health - MH).

References

    1. Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004;12(8):642–649. doi: 10.1016/j.joca.2004.04.010.
    1. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25(11):2203–2212.
    1. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. Cmaj. 2005;172(8):1039–1043. doi: 10.1503/cmaj.1041203.
    1. Bullinger M. German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med. 1995;41(10):1359–1366. doi: 10.1016/0277-9536(95)00115-N.
    1. Carr AJ. Beyond disability: measuring the social and personal consequences of osteoarthritis. Osteoarthritis Cartilage. 1999;7(2):230–238. doi: 10.1053/joca.1998.0154.
    1. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44(12):817–822. doi: 10.1136/ard.44.12.817.
    1. Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum. 1994;37(4):521–528. doi: 10.1002/art.1780370412.
    1. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993. pp. 97–103.
    1. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343–1355. doi: 10.1002/1529-0131(199808)41:8<1343::AID-ART3>;2-9.
    1. Hermens H, J FB, Merletti R, Stegemann D, Blok J, Rau G, Disselhorst-Klug C, Hägg G. Results of the SENIAM project. Roessingh Research and Development bv; 1999. European recommendations for surface electromyography.
    1. Huskisson EC. Measurement of pain. Lancet. 1974;2(7889):1127–1131.
    1. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clinical Orthopaedics and Related Research. 1989. pp. 13–14.
    1. Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage. 1995;3(4):269–273. doi: 10.1016/S1063-4584(05)80018-4.
    1. Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford) 2002;41(11):1240–1248. doi: 10.1093/rheumatology/41.11.1240.
    1. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502. doi: 10.1136/ard.16.4.494.
    1. Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2005.
    1. Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am. 2003;85-A(7):1197–1203.
    1. Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987;65:85–89.
    1. Miltner O, Schneider U, Siebert CH, Niedhart C, Niethard FU. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis--a prospective clinical trial. Osteoarthritis Cartilage. 2002;10(9):680–686. doi: 10.1053/joca.2002.0815.
    1. Petrella RJ. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil. 2005;84(4):278–283. doi: 10.1097/01.PHM.0000156899.18885.06. quiz 284, 293.
    1. Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33(5):951–956.
    1. Peyron JG. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthritis Cartilage. 1993;1(2):85–87. doi: 10.1016/S1063-4584(05)80022-6.
    1. Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, Uthman I, Khy V, Tremblay JL, Bertrand C, Pelletier JP. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48(2):370–377. doi: 10.1002/art.10777.
    1. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage. 2002;10(7):506–517. doi: 10.1053/joca.2002.0798.
    1. Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19(3):265–270.
    1. Tang SF, Chen CP, Chen MJ, Hong WH, Yu TY, Tsai WC. Improvement of muscle strength in osteoarthritic knee patients after intraarticular knee injection of hyaluronan. Am J Phys Med Rehabil. 2005;84(4):274–277. doi: 10.1097/01.PHM.0000156894.57879.7D.
    1. Tang SF, Chen CP, Chen MJ, Pei YC, Lau YC, Leong CP. Changes in sagittal ground reaction forces after intra-articular hyaluronate injections for knee osteoarthritis. Arch Phys Med Rehabil. 2004;85(6):951–955. doi: 10.1016/j.apmr.2003.08.095.
    1. Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthritis Cartilage. 2002;10(7):518–527. doi: 10.1053/joca.2001.0513.
    1. Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19(1):19–27.
    1. Yavuzer G, Sonel B, Suldur N, Ergin S. Effects of intraarticular hylan G-F 20 injections on clinical and biomechanical characteristics of the knee in osteoarthritis. Int J Rehabil Res. 2005;28(4):371–374. doi: 10.1097/00004356-200512000-00013.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe